WallStreetZenWallStreetZen

NASDAQ: HOWL
Werewolf Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

HOWL past revenue growth

How has HOWL's revenue growth performed historically?
Company
21.6%
Industry
145.73%
Market
17.2%
HOWL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
HOWL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
HOWL's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

HOWL earnings and revenue history

Current Revenue
$19.9M
Current Earnings
-$37.4M
Current Profit Margin
-187.4%

HOWL Return on Equity

Current Company
-32.2%
Current Industry
-63.5%
Current Market
188%
HOWL's Return on Equity (-32.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when HOWL announces earnings.

HOWL Return on Assets

Current Company
-20.4%
Current Industry
2.9%
HOWL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

HOWL Return on Capital Employed

Current Company
-22.02%
Current Industry
19.5%
HOWL's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HOWL vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
HOWL$19.94M-$30.89M-$37.37M+21.60%N/A
BDTX$0.00-$82.01M-$82.44MN/AN/A
ENTA$73.62M-$124.91M-$138.24M-20.94%N/A
INZY$0.00-$66.51M-$71.17MN/AN/A
ADAP$60.28M-$102.70M-$113.87M+0.26%N/A
View Top Biotech Stocks

HOWL earnings dates

Next earnings date
May 8, 2024

Werewolf Therapeutics Earnings & Revenue FAQ

What were HOWL's earnings last quarter?

On Invalid Date, Werewolf Therapeutics (NASDAQ: HOWL) reported Q4 2023 earnings per share (EPS) of -$0.33, up 13.16% year over year. Total Werewolf Therapeutics earnings for the quarter were -$12.00 million. In the same quarter last year, Werewolf Therapeutics's earnings per share (EPS) was -$0.38.

If you're new to stock investing, here's how to buy Werewolf Therapeutics stock.

What was HOWL's earnings growth in the past year?

As of Q2 2024, Werewolf Therapeutics's earnings has grown year over year. Werewolf Therapeutics's earnings in the past year totalled -$37.37 million.

What is HOWL's earnings date?

Werewolf Therapeutics's earnings date is Invalid Date. Add HOWL to your watchlist to be reminded of HOWL's next earnings announcement.

What was HOWL's revenue last quarter?

On Invalid Date, Werewolf Therapeutics (NASDAQ: HOWL) reported Q4 2023 revenue of $1.50 million up 79.39% year over year. In the same quarter last year, Werewolf Therapeutics's revenue was $7.28 million.

What was HOWL's revenue growth in the past year?

As of Q2 2024, Werewolf Therapeutics's revenue has grown 21.6% year over year. This is 124.14 percentage points lower than the US Biotechnology industry revenue growth rate of 145.73%. Werewolf Therapeutics's revenue in the past year totalled $19.94 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.